The NIDDK-supported Centers for Diabetes Translation Research (CDTR) are part of an integrated program whose cores support and enhance diabetes type II translation research (e.g. bedside to practice and the community, dissemination and implementation science). NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research.
The purpose of the CDTRs is to enhance the efficiency, productivity, effectiveness and multidisciplinary nature of diabetes translation research. Centers are intended to improve the quality and multidisciplinary nature of research of diabetes translational research through shared access to specialized technical expertise. The Centers objectives are to bring together investigators from relevant disciplines in a manner that will enhance and extend the effectiveness of their research.
The CDTRs serve as a key component of the NIDDK-supported research program to translate efficacious research findings into practice and the community to improve the health of Americans with, or at risk for, diabetes. CDTRs will enhance scientific progress and improve the uptake of research by providing support and expertise for rigorous translation research aimed at prevention and improved treatment of diabetes (type 1, type 2 and gestational) and related conditions. To meet these goals, CDTRs will provide core services and consultation locally, regionally, and nationally in areas relevant to the NIDDK translation research agenda. To learn more about the NIDDK type II translation research priorities in diabetes, please see the Clinical Research to Practice: Translational Research chapter in Advances and Emerging Opportunities in Diabetes Research: A Strategic Planning Report of the Diabetes Mellitus Interagency Coordinating Committee (DMICC).